Flu Cases Surge as CDC Reports Rising Hospitalizations

Dec 31, 2025, 2:44 AM
Image for article Flu Cases Surge as CDC Reports Rising Hospitalizations

Hover over text to view sources

Flu season is off to a challenging start this year, according to the Centers for Disease Control and Prevention (CDC). The latest data indicates that flu cases are rising at an alarming rate compared to previous years, with significant implications for public health.
Last week, more than 19,000 patients with influenza were admitted to hospitals, marking an increase of about 10,000 from the previous week. To date, the CDC estimates that at least 7.5 million people have been infected, and over 3,100 individuals have died from the flu this season.
The surge in cases appears to be driven primarily by a new strain of the virus, specifically subclade K of influenza A(H3N2), which emerged in Australia over the summer. Andrew Pekosz, a virologist at Johns Hopkins Bloomberg School of Public Health, noted that wherever this virus is detected, a significant increase in influenza cases typically follows. He emphasized that while the timing of the flu season is similar to previous years, the rapid increase in cases is unusual for this time of year.
New York has been particularly hard hit, with state health officials reporting over 71,000 cases last week, the highest number recorded in a single week in the state's history. Other regions, especially in the northeast, midwest, and south, are also experiencing elevated levels of flu activity. Pekosz remarked that the current map of flu activity is predominantly red, indicating high levels of disease that are likely to escalate in the coming weeks.
Despite the concerning rise in cases, there is currently no evidence that this new strain is more severe or contagious than those seen in previous years. However, virologist Florian Krammer from the Icahn School of Medicine at Mount Sinai pointed out that changes in the virus may allow it to evade immune defenses more effectively. This reduced immunity is contributing to the rapid spread of the virus across the population.
There are growing concerns regarding the effectiveness of this season's flu vaccine, as it may not be a perfect match for the circulating strain. Demetre Daskalakis, former head of the National Center for Immunization and Respiratory Diseases at the CDC, indicated that a mismatch between the circulating strain and the vaccine is likely. Nevertheless, he emphasized that the vaccine remains the best form of protection available, even if it is not fully effective.
Preliminary data from the United Kingdom, which experienced an early flu surge, suggests that the vaccine is approximately 30 to 40% effective at preventing hospitalization in adults. Krammer noted that these figures align with typical expectations for flu vaccine efficacy, although they are still preliminary estimates.
In response to the surge, health officials stress the importance of vaccination. However, only 42% of adults in the US have received a flu shot this year, leaving many unprotected as the flu season intensifies. Daskalakis criticized the CDC for not doing enough to promote vaccination, stating that there should be more robust communication and alerts encouraging people to get vaccinated.
In light of these challenges, the CDC has launched a national outreach campaign aimed at raising awareness and empowering Americans with the necessary tools to stay healthy during the respiratory illness season. A CDC spokesperson reiterated that the decision to vaccinate is personal and encouraged individuals to consult with their healthcare providers about their options and the associated risks and benefits of vaccines.
In addition to vaccination, there are other protective measures individuals can take. Krammer advises wearing masks, particularly in crowded settings or on public transportation, to reduce the risk of transmission. He also recommends social distancing, especially if someone in the household is infected. If an individual does contract the flu, effective treatment options are available, particularly if initiated within 48 hours of infection. Krammer emphasized the importance of seeking medical advice if flu symptoms arise, as influenza should not be taken lightly.
As flu cases continue to rise, public health officials urge vigilance and proactive measures to mitigate the impact of this year's flu season.

Related articles

FDA Rejects Outlook's Eye Drug Lytenava for Second Time

The FDA has declined to approve Outlook Therapeutics' eye disease drug, Lytenava, for the second time, citing insufficient evidence of effectiveness. This decision follows a previous rejection in 2023 due to manufacturing issues and the need for more clinical data.

U.S. Measles Cases Surge to Highest Level in Over 30 Years

The Centers for Disease Control and Prevention (CDC) reports that US measles cases have reached their highest level in over 30 years, with 1,288 confirmed cases across 38 states. The resurgence is attributed to declining vaccination rates and significant outbreaks, particularly in Texas.

US Measles Cases Exceed 2,000, Highest in 30 Years: CDC

The Centers for Disease Control and Prevention (CDC) reports that the United States has surpassed 2,000 confirmed measles cases for the first time in over three decades. As of December 23, 2025, a total of 2,012 cases have been documented, with a significant portion linked to outbreaks, particularly in South Carolina.

Dartmouth Hitchcock Medical Center Named Among Top 100 Hospitals for 2025

Dartmouth Hitchcock Medical Center (DHMC) has been recognized by Becker's Hospital Review as one of America's top 100 hospitals for 2025. This accolade highlights DHMC's commitment to academic medicine and rural healthcare delivery, alongside its advanced medical transport services.

Flu Activity Surges in the US with 7.5 Million Illnesses: CDC

Flu activity has sharply increased across the United States, with the CDC reporting at least 7.5 million illnesses, 81,000 hospitalizations, and 3,100 deaths this season. The rise is attributed to a new flu variant, subclade K, which has led to significant respiratory illness activity, particularly among children and young adults.